NewAmsterdam Pharma

NewAmsterdam drug cuts cholesterol, but by less than expectations, in phase 3 test
Fierce Biotech
Mon, 07/29/24 - 10:27 am
NewAmsterdam Pharma
cholesterol
clinical trials
obicetrapib
HeFH
IPOs vs SPACs
EP Vantage
Thu, 03/9/23 - 09:47 am
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
Fierce Biotech
Tue, 01/17/23 - 10:32 am
NewAmsterdam Pharma
Amgen
CETP inhibitors
obicetrapib
clinical trials
NewAmsterdam Pharma to Merge With SPAC Frazier Lifesciences
Marketwatch
Mon, 07/25/22 - 10:49 am
NewAmsterdam Pharma
M&A
SPAC
Frazier Lifesciences
A much-hyped CV drug failed, repeatedly. Now, investors are betting nearly $200M on one last PhIII bid
Endpoints
Thu, 01/14/21 - 10:45 am
Eli Lilly
cardiovascular disease
NewAmsterdam Pharma
CETP inhibitors
A new biotech forms to revive Amgen's old heart drug
BioPharma Dive
Thu, 08/27/20 - 10:57 am
Amgen
NewAmsterdam Pharma
obicetrapib
heart disease